Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose for Postprandial Glycemia in Pediatric Obesity
NCT00846521Phase 4Terminated
- Sponsor
- Yale University
- Start
- Sep 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of acarbose in impaired glucose tolerance (IGT), sponsored by Yale University. Primary endpoint: Mean Percentage of Glucose Values ≥ 140 mg/dl Over 72 Hours at 6 weeks. Started Sep 2006; status: terminated.
02
Drugs
acarbose
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00846521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00846521.